|
JSPRW Japer Therapeutics 1788028 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-2,760,000.00 |
| Balance Sheet |
|
Current Assets
|
$11,571,000.00 |
|
Assets
|
$11,802,000.00 |
|
Current Liabilities
|
$7,845,000.00 |
|
Liabilities
|
$10,389,000.00 |
|
Equity
|
$1,413,000.00 |
|
Shares Out
|
28079552.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-21,467,000.00 |
|
Investing Cash Flow
|
$80,000.00 |
| Market Analysis |
Market Cap
|
$280,795.52 |
|
Price
|
$0.01 |
|
BVPS
|
0.05 |
|
PB
|
0.20 |
|
EPS
|
-0.10 |
|
FCF
|
$-21,474,000.00 |
|
| Dividends |
|
Dividend Amount
|
0.04 |
|
Dividend Data Last Updated
|
2026-09-01 09:33:18 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:02:07 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view JSPRW documents filed with the SEC.
JSPRW Filings
Clear
